Exchange: OTC·Updated 12:51 PM EDT

BSEM Earnings

Latest Earnings Results: Q2 '26

Reported: Aug 12

Estimated EPS

-$0.50

Reported EPS

-$0.52

Surprise

-4%

Estimated Rev

$6.35M

Reported Rev

$7.9M

Surprise

+24.36%

BioStem Technologies reported Q2 2026 net revenue of $7.9M, a 28% YoY decrease, driven by CMS reimbursement changes that reduced physician office revenue by 90% compared to Q2 2025.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.43
--
--
N/A
Q2 '26
-$0.50
-$0.52
-4.00%
MISSED
Q1 '26
-$0.28
-$0.52
-85.71%
MISSED
Q4 '25
$0.02
-$0.67
-3450.00%
MISSED
Q3 '25
$0.00
$0.03
100.00%
BEAT

Advertisement|Remove ads.